Inspiratory flow rate through a dry powder inhaler (Clickhaler®) in children with asthma

Pediatric Pulmonology

Volumn 35, Issue 3, 2003, Pages 220-226

  Parry Billings, Mark ^a   Birrell, Claire ^a   Oldham, Louise ^a   O'Callaghan, Christopher ^b  

^a Innovata Biomed Ltd   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Asthma; Children; Clickhaler ; Dry powder inhaler; Peak inspiratory flow

Indexed keywords

ASMABEC; ASMASAL; BECLOMETASONE DIPROPIONATE; SALBUTAMOL;

ADOLESCENT; AEROSOL; AGE DISTRIBUTION; AIRWAY DYNAMICS; ARTICLE; ASTHMA; CHILDHOOD DISEASE; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRY POWDER; FEMALE; FLOW MEASUREMENT; FORCED EXPIRATORY VOLUME; HUMAN; INSPIRATORY CAPACITY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; PEAK INSPIRATORY FLOW; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; SCHOOL CHILD; STATISTICAL ANALYSIS; TISSUE DISTRIBUTION;

ADOLESCENT; AEROSOLS; ASTHMA; CHILD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; RESPIRATORY MECHANICS;

EID: 0037369920     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.10234     Document Type: Article

References (33)

1. National Institutes of Health. National Heart, Lung and Blood Institute. Expert panel report 2. Guidelines for the diagnosis and management of asthma. NIH publication no. 97-4051, July 1997.
2. Srichana T, Martin GP, Marriott C. Dry powder inhalers: the influence of device resistance and powder formulation on drug and lactose deposition in vitro. Eur J Pharm Sci 1998;7:73-80.
3. Ganderton D. General factors influencing drug delivery to the lung. Respir Med [Suppl] 1997;91:13-16.
4. Chege JK, Chrystyn H. The relative bioavailability of salbutamol to the lung using urinary excretion following inhalation from a novel dry powder inhaler: the effect of inhalation rate and formulation. Respir Med 2000;94:51-56.
5. Everard ML, Devadason SG, Le Souëf PN. Flow early in the inspiratory manoeuvre affects the aerosol particle size distribution from a Turbuhaler. Respir Med 1997;91:624-628.
6. Newman SP, Morén F, Trofast E, Talaee N, Clarke SW. Terbutaline sulphate Turbuhaler: effect of inhaled flow rate on drug deposition and efficacy. Int J Pharmaceutics 1991;74:209-213.
7. Persson G, Olsson B, Soliman S. The impact of inspiratory effort on inspiratory flow through Turbuhaler® in asthmatic patients. Eur Respir J 1997;10:681-684.
8. Parry-Billings M, Boyes RN, Clisby LM, Braithwaite P, Williams S, Harper AE. Design, development, and performance of a novel multidose dry-powder inhaler. Pharm Tech 1999;23:70-81.
9. Newhouse MT, Nantel NP, Chambers C, Pratt B, Parry-Billings M. Clickhaler™ (a novel dry powder inhaler) provides similar bronchodilation to pressurized metered-dose inhaler, even at low flow rates. Chest 1999;115:952-956.
10. Morice AH, Peake MD, Allen MB, Campbell JC, Parry-Billings M. Reproducibility of bronchodilator response for a reservoir dry powder inhaler following routine clinical use. J Asthma 2000;37:81-87.
11. Morice AH, Andrews B, Taylor M. Comparison of the effect on bronchial hyperresponsiveness of beclomethasone dipropionate administered via a novel multidose dry powder inhaler or a conventional pressurised metered dose inhaler. Respiration 2000;67:298-305.
12. O'Callaghan C, Everard ML, Bush A, Hiller EJ, Ross-Russell R, O'Keefe P, Weller P. Salbutamol dry powder inhaler: efficacy, tolerability, and acceptability study. Pediatr Pulmonol 2002;33:189-193.
13. Adler LM, Anand C, Wright FGL, Barrett CF, McKeith D, Clark WIC, Maksimczyk P, Martin GDR, McKinnon C, Raffles AKM, Buck H. Efficacy and tolerability of beclomethasone dipropionate delivered by a novel multidose dry powder inhaler (Clickhaler®) versus a metered dose inhaler in children with asthma. Curr Ther Res Clin Exp 2001;62:758-769.
14. Barrowcliffe J, McGlynn P, Tickle S, Sandbank F, Wong T. The in-vitro evaluation of a novel multi-dose dry powder inhaler. Drug Delivery Lungs 1996;7:82-85.
15. Newhouse MT, Chambers C, Jones RD, Morice AH. Clickhaler®: a novel dry powder inhaler effective at patient-achievable inspiratory flow rates. J Aerosol Med 1999;12:120.
16. Barrowcliffe J, McGlynn P, Ratcliffe S, Sewell M, Sheikh S, Walters M. Beclomethasone dipropionate (BDP) Clickhaler™: in vitro performance of a steroid novel dry powder inhaler. Drug Delivery Lungs 1997;8:125-128.
17. Smith IJ, Parry-Billings M. The inhalers of the future? A review of dry powder devices on the market today. Pulm Pharmacol Ther (in press).
18. Warren SJ, Taylor G. Effect of inhalation flow profiles on the deposition of radiolabelled BDP from a novel dry powder inhaler (DPI, Clickhaler™), a conventional metered dose inhaler (MDI) and MDI plus spacer. Respir Drug Delivery 1998;6:453-455.
19. Nantel NP, Newhouse MT. Inspiratory flow rates through a novel dry powder inhaler (Clickhaler) in pediatric patients with asthma. J Aerosol Med 1999;12:55-58.
20. Quanjer PH, Stocks J, Polgar G, Wise M, Karlberg J, Borsboom G. Compilation of reference values for lung function measurements in children. Eur Respir J [Suppl] 1989;2:184-261.
21. Huchon GJ, Dessanges JF, Pin I, Aiache J-M, Barthe J, Perilliat JG. Peak inspiratory flow (PIF) when using a dry powder inhaler in asthmatics and COPD. Eur Respir J [Suppl] 2001;18:99.
22. Iqbal SM, Ritson S, Buck H, Ellis S, Everard M. Assessment of inspiratory flow (IF) through the Clickhaler® dry powder inhaler (DPI) in children (2 to 5 years). Am J Respir Crit Care Med 2001;163:3.
23. Agertoft L, Pedersen S. Importance of training for correct Turbuhaler use in preschool children. Acta Paediatr Scand 1998;87:842-847.
24. Everard ML. CFC transition: the emperor's new clothes. Each class of drug deserves a delivery system that meets its own requirements. Thorax 2000;55:811-814.
25. Janssens HM, Devadason SG, Hop WCJ, et al. Variability of aerosol delivery via spacer devices in young children in daily life. Eur Respir J 1999;13:787-791.
26. Pedersen S. Delivery options for inhaled therapy in children over the age of 6 years. J Aerosol Med 1997;10:41-44.
27. Pedersen S, Hansen OR, Fuglsang G. Influence of inspiratory flow rate upon the effect of a Turbuhaler. Arch Dis Child 1990;65:308-310.
28. Brown PH, Ning AC, Greening AP, McLean A, Crompton GK. Peak inspiratory flow through turbohaler in acute asthma. Eur Respir J 1995;8:1940-1941.
29. Lenny W, Wells NEJ, O'Neil BA. The burden of paediatric asthma. Eur Respir Rev 1994;4:49-62.
30. International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide prevalence of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema. Lancet 1998;351:1225-1232.
31. Pedersen S, Frost L, Arndred T. Errors in inhalation technique and efficiency in inhaler use in asthmatic children. Allergy 1986;41:118-124.
32. Gibson NA, Ferguson AE, Aitchison TC, et al. Compliance with inhaled asthma medication in pre-school children. Thorax 1995;50:1274-1279.
33. Chlorofluorocarbon propellants in self-pressurized containers; determinations that uses are no longer essential; request for comments. Fed Reg 1997;62:10242-10246.